Peptides for Powerlifters and Strongman: Healing Joints and Tendons Under Maximal Load

Four Weeks Out, and the SI Joint Goes

Every powerlifter and strongman athlete has a version of this. The elbow that starts barking in the middle of a bench cycle. The patellar tendon that aches on every squat below parallel. The pec that pulls on the lowering phase of a max attempt. The wear of moving the heaviest weights a body can move does not show up as general fatigue. It shows up as a specific structure, in a specific spot, that has had enough.

Peptide therapy has become part of how some strength athletes manage that connective-tissue wear. The catch is that almost all of the content about it online is written for bodybuilders chasing a cut or for muscle growth, which is a different goal and a different physiology. This guide is built for the strength athlete: what heavy lifting actually injures, lift by lift, and the peptides used for that connective-tissue repair. It is not about getting bigger or leaner. It is about keeping the joints and tendons intact under load.

It Is Almost Never the Muscle

Here is the thing that separates strength-sport injury from almost everything else. Muscle is highly vascular, it heals fast, and a strained muscle is usually back in weeks. The structures that actually end training blocks are the ones with poor blood supply: tendons, ligaments, and the dense connective tissue around joints. Those heal slowly precisely because so little blood reaches them, and that is why ice, rest, and ibuprofen so often leave you stuck in a months-long holding pattern.

This matters for peptide selection because the peptide most used by lifters, BPC-157, has a mechanism that speaks directly to that problem: it promotes angiogenesis, the growth of new blood vessels into healing tissue. For tissue that is starved of blood flow to begin with, improving the blood supply is the lever that the standard recovery toolkit does not pull.

What Each Lift Actually Tears

No peptide retailer has bothered to write this down, so here it is. The injuries of strength sport are predictable from the movements, and naming the tissue is the first step to targeting it.

The common thread down the right-hand column is that these are tendinopathies and connective-tissue injuries, not muscle tears. That is the category BPC-157 is used for, and it is why a single-peptide answer covers so much of the strength-sport injury map.

The Core Tool: BPC-157

BPC-157 is a synthetic peptide based on a sequence found in human gastric juice, and it is the one most associated with tendon and soft-tissue recovery. The human research is still limited, but the preclinical body of work is large and consistent: across many animal models it accelerates the healing of tendon, ligament, muscle, and even bone, with the angiogenesis mechanism described above as a central part of the story.

For lifters, the appeal is that it targets the slow-healing structures that derail training blocks. The elbow tendinopathy from heavy pressing, the patellar tendon from squat volume, the soft-tissue side of an SI flare. Athletes typically run it daily for a focused block while reducing load on the injured area, which is the part that matters most. EliteFTS and other strength-native outlets have published on BPC-157 for exactly this kind of rehab, which tells you the strength community is already using it this way.

BPC-157 is available both as an oral capsule and as a subcutaneous injection. The gut-derived origin is part of why the oral form is used at all, though many lifters use the injection for systemic or nearer-to-site work. A provider sets the form and protocol.

When It Is Worse: The BPC-157/TB-500 Combo

For higher-grade or stubborn soft-tissue work, the BPC-157/TB-500 combo is the more aggressive option. TB-500 is a synthetic fragment related to thymosin beta-4, a protein involved in cell migration, actin regulation, and tissue repair. Its mechanism is complementary to BPC-157 rather than redundant, which is the rationale for combining them. Where BPC-157 leans on angiogenesis and gut-derived repair signaling, TB-500 supports the cellular migration side of healing.

The Older Lifter: Tesamorelin

Tesamorelin is a different lever, and it is most relevant to the masters lifter. It is a growth-hormone-releasing hormone analog, meaning it prompts the body to produce more of its own growth hormone. Growth hormone plays a role in collagen synthesis and connective-tissue turnover, both of which decline with age, and that decline is a real part of why recovery slows and tendons get crankier in a lifter’s 40s and 50s.

Used in that context, Tesamorelin is about supporting the recovery capacity and collagen turnover that time erodes, rather than fixing a specific acute injury. It is a longer-arc, systemic tool, where BPC-157 is the targeted one. The two address different parts of the same problem for an older strength athlete: less downtime between heavy sessions, and better repair of the connective tissue that takes the load.

Tested Federations: The WADA Note

Powerlifting splits cleanly into tested and untested federations, and which one you compete in changes everything about whether these tools are even an option.

Untested federations do not screen for these substances, so the testing risk does not apply there. What applies regardless of federation: every peptide in this guide is prescription-only in the US, none are FDA-approved for athletic recovery, and the legal path runs through a licensed provider and a real pharmacy. If you are a tested lifter, verify everything against the current WADA Prohibited List, which is updated each January, and understand that "I did not know" is not a defense. We would rather state that plainly than let a meet get taken away over it.

A Few Practical Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed June 2026